Zobrazeno 1 - 10
of 22
pro vyhledávání: '"D. R. Prevots"'
Autor:
Adrian M. Zelazny, Reginald J. Claypool, Pamela A. Shaw, Kenneth N. Olivier, Monika Fleshner, Jennifer Adjemian, D. R. Prevots, Steven M. Holland, Sara Strollo, Les R. Folio
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 20(5)
Setting Tertiary referral center, National Institutes of Health (NIH), USA. Objective To estimate the mortality rate and its correlates among persons with pulmonary non-tuberculous mycobacteria (PNTM) disease. Design A retrospective review of 106 pat
Autor:
Sameer S Kadri, Jennifer Adjemian, D. R. Prevots, Emily Ricotta, Yi Ling Lai, Michail S. Lionakis
Publikováno v:
Open Forum Infectious Diseases
Background While 50% of invasive candidiasis (IC) has historically been caused by C. albicans, the changing epidemiology and rise in drug-resistant Candida necessitates understanding the contribution of specific Candida species to IC. To date, specie
Autor:
Kenneth N. Olivier, D. R. Prevots, Ong B, Kloetzal M, Mann K, Jennifer Adjemian, Emily Ricotta, Gould C, Gross J
Publikováno v:
Open Forum Infectious Diseases
Background Persons with cystic fibrosis (CF) are at increased risk for nontuberculous mycobacteria (NTM) lung infections, with a national annual prevalence of 13%. However, for CF patients in Hawaii, estimates are as high as 50%. Active duty military
Publikováno v:
Open Forum Infectious Diseases
Background Nontuberculous mycobacteria (NTM) are associated with human lung disease, with 80% of cases caused by Mycobacterium avium complex (MAC). American Thoracic Society (ATS)-led treatment guidelines exist for MAC (macrolide/ethambutol/rifamycin
Autor:
Sunil Pandya, Nino Khetsuriani, Kristine M. Bisgard, Graham Dameron, Angela Poppe, Patricia Quinlisk, Melinda Wharton, Muireann Brennan, D R Prevots, Kot Flora
Publikováno v:
The Pediatric Infectious Disease Journal. 20:1108-1112
An outbreak of pertussis in a US elementary school with high vaccination coverage was investigated to evaluate vaccine effectiveness and to identify potential contributing factors.Survey and cohort study of all 215 students of an elementary school (i
Publikováno v:
Pediatric Clinics of North America. 47:287-308
Poliomyelitis prevention in the United States has relied virtually exclusively on OPV during the past 30 years. Starting in 1997, a major change in the poliomyelitis vaccination policy occurred, facilitated by substantial progress toward worldwide po
Publikováno v:
C25. ADVANCES IN NON-TUBERCULOUS MYCOBACTERIA: NON-TUBERCULOUS MYCOBACTERIA DISEASE.
Autor:
Reginald J. Claypool, D. R. Prevots, Michelle L. Paulson, Andrea G. Henkel, Steven M. Holland, Kenneth N. Olivier
Publikováno v:
C25. ADVANCES IN NON-TUBERCULOUS MYCOBACTERIA: NON-TUBERCULOUS MYCOBACTERIA DISEASE.
Autor:
Darshana Bhattacharyya, Pamela A. Shaw, Kenneth N. Olivier, Tanya S. Glaser, Steve Holland, D. R. Prevots
Publikováno v:
A105. NONTUBERCULOUS MYCOBACTERIA: PATHOPHYSIOLOGY TO TREATMENT.
Publikováno v:
C56. BENCH TO BEDSIDE ADVANCES IN BRONCHIECTASIS.